Tech Company Financing Transactions
Plasmonix Funding Round
Private investors participated in a $314.9 thousand capital raise for Plasmonix. This venture round was announced on 6/16/2014.
Transaction Overview
Company Name
Announced On
6/16/2014
Transaction Type
Venture Equity
Amount
$314,942
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9119 Gaither Rd.
Gaithersburg, MD 20877
USA
Gaithersburg, MD 20877
USA
Phone
Website
Email Address
Not Recorded
Overview
Plasmonix's focus is on enhancement of luminescent signals through advanced use of metal nanoparticles and application of its technology in life science and diagnostic assays.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jesse Baumgold
Browse more venture capital transactions:
Prev: 6/16/2014: Presidio Pharmaceuticals venture capital transaction
Next: 6/16/2014: Patch of Land venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs